clinicaltrialsarena4h
How logistics shape the success of rare disease trials
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...
clinicaltrialsarena23h
Neurogene’s stock sinks after adverse event with Rett syndrome gene therapy
Neurogene's stock price collapsed by 34.8% in pre-market trading after announcing data from the Phase I/II Rett syndrome ...
clinicaltrialsarena20h
Arch Biopartners doses first subject in trial of acute kidney injury treatment
Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of LSALT peptide (Metablok) for acute ...
clinicaltrialsarena22h
AbbVie’s stock plummets over 12% after schizophrenia drug flops in Phase II trials
AbbVie’s stock price fell over 12% after emraclidine failed to meet its primary endpoints in the company’s Phase II ...